EPISODE · Jul 27, 2021 · 23 MIN
Anabolic Therapy for Osteoporosis
Anabolic drugs activate osteoblasts and are an alternative to bisphosphonates for treating osteoporosis. Kristine Ensrud, MD, MPH, professor of medicine and epidemiology at the University of Minnesota and Minneapolis VA Healthcare System, joins JAMA Associate Editor Carolyn Crandall, MD, MS, to discuss the role of teriparatide, abaloparatide, and romosozumab in the management of osteoporosis. Related Content: Anabolic Therapy for Osteoporosis
Embed this episode
NOW PLAYING
Anabolic Therapy for Osteoporosis
0:00
23:29
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JAMA Clinical Reviews?
This episode is 23 minutes long.
When was this JAMA Clinical Reviews episode published?
This episode was published on July 27, 2021.
Can I download this JAMA Clinical Reviews episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!